A combinatorial culture strategy to develop pseudomyxoma peritonei organoid models.

IF 2 3区 医学 Q3 ONCOLOGY
Luca Varinelli, Marzia Di Bella, Marcello Guaglio, Davide Battistessa, Federica Pisati, Tommaso Cavalleri, Massimo Milione, Jordi Martínez-Quintanilla, Patrick T Caswell, Dario Baratti, Shigeki Kusamura, Marcello Deraco, Manuela Gariboldi
{"title":"A combinatorial culture strategy to develop pseudomyxoma peritonei organoid models.","authors":"Luca Varinelli, Marzia Di Bella, Marcello Guaglio, Davide Battistessa, Federica Pisati, Tommaso Cavalleri, Massimo Milione, Jordi Martínez-Quintanilla, Patrick T Caswell, Dario Baratti, Shigeki Kusamura, Marcello Deraco, Manuela Gariboldi","doi":"10.1002/jso.27850","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Few preclinical models of pseudomyxoma peritonei (PMP) have been developed, probably due to the tumor's low incidence and its peculiar characteristics of slow growth. Therefore, there is a need to develop more refined PMP models that better reflect its characteristics. The aim of the study is to develop a culture strategy to generate organoid models derived from PMP patient samples.</p><p><strong>Methods: </strong>We followed a strategy based on combinatorial culture conditions that include the different factors essential for PMP growth and that mimic the microenvironment present in the patients.</p><p><strong>Results: </strong>We cultured PMP samples in the presence of the various factors produced by the niche environment of PMP. We obtained 12 PMP organoid models, each of which grows under specific culture conditions. PMP-derived organoids show long-term expansion capacity and reproduce the genetic landscape and histological phenotype of the tumor of origin.</p><p><strong>Conclusion: </strong>The organoids we developed faithfully reproduce the key features of PMP disease and will allow us to understand the biology of PMP. With them, we will be able to identify key regulatory networks that support PMP progression, providing a platform for multilevel preclinical testing, identify novel diagnostic biomarkers, and generate novel targets for patient treatments.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jso.27850","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Few preclinical models of pseudomyxoma peritonei (PMP) have been developed, probably due to the tumor's low incidence and its peculiar characteristics of slow growth. Therefore, there is a need to develop more refined PMP models that better reflect its characteristics. The aim of the study is to develop a culture strategy to generate organoid models derived from PMP patient samples.

Methods: We followed a strategy based on combinatorial culture conditions that include the different factors essential for PMP growth and that mimic the microenvironment present in the patients.

Results: We cultured PMP samples in the presence of the various factors produced by the niche environment of PMP. We obtained 12 PMP organoid models, each of which grows under specific culture conditions. PMP-derived organoids show long-term expansion capacity and reproduce the genetic landscape and histological phenotype of the tumor of origin.

Conclusion: The organoids we developed faithfully reproduce the key features of PMP disease and will allow us to understand the biology of PMP. With them, we will be able to identify key regulatory networks that support PMP progression, providing a platform for multilevel preclinical testing, identify novel diagnostic biomarkers, and generate novel targets for patient treatments.

开发腹膜假性肌瘤类器官模型的组合培养策略
背景和目的:可能由于假性腹膜肌瘤(PMP)发病率低且生长缓慢的特殊性,目前已建立的假性腹膜肌瘤临床前模型寥寥无几。因此,有必要建立更完善的 PMP 模型,以更好地反映其特征。本研究的目的是开发一种培养策略,从 PMP 患者样本中生成类器官模型:方法:我们采用了一种基于组合培养条件的策略,其中包括 PMP 生长所必需的不同因子,并模拟患者体内的微环境:结果:我们在PMP龛位环境产生的各种因素存在下培养了PMP样本。我们获得了12个PMP类器官模型,每个模型都在特定的培养条件下生长。PMP衍生的类器官显示出长期扩增能力,并再现了原发肿瘤的遗传学特征和组织学表型:我们开发的器官组织忠实地再现了 PMP 疾病的主要特征,将使我们能够了解 PMP 的生物学特性。有了它们,我们就能确定支持 PMP 进展的关键调控网络,为多层次临床前测试提供平台,确定新的诊断生物标志物,并为患者治疗产生新的靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.70
自引率
4.00%
发文量
367
审稿时长
2 months
期刊介绍: The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信